ivabradine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baka, T; Luptak, I; Repova, K; Simko, F | 1 |
| Aggarwal, D; Aronow, WS; Kantharia, B; Narasimhan, B; Satish, P | 1 |
| Lyne, A; O'Sullivan, JS; Vaughan, CJ | 1 |
1 review(s) available for ivabradine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies.
Topics: COVID-19; Deamino Arginine Vasopressin; Erythropoietin; Fludrocortisone; Humans; Immunoglobulins, Intravenous; Iron; Ivabradine; Midodrine; Postural Orthostatic Tachycardia Syndrome; Therapies, Investigational; Thioctic Acid; Vitamin D | 2022 |
2 other study(ies) available for ivabradine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A Perspective.
Topics: Benzazepines; COVID-19; COVID-19 Drug Treatment; Heart Rate; Humans; Ivabradine; Myocarditis; Shock, Cardiogenic | 2022 |
COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine.
Topics: Adult; COVID-19; Female; Humans; Ivabradine; Postural Orthostatic Tachycardia Syndrome; SARS-CoV-2; Tachycardia, Sinus; Young Adult | 2021 |